Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.41 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.41 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.41 |
| ▸ | CAD | P27708 | 1/20 | 0.41 |
| ▸ | GABRP | O00591 | 2/20 | 0.40 |
| ▸ | GABRD | O14764 | 2/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.40 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.40 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.40 |
| ▸ | GABRE | P78334 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4629355 | 1.00 | L3MBTL1 (0.59) | L3MBTL1KMT2APOLBNOD1FOLH1 | |
| SCHEMBL3870882 | 0.87 | L3MBTL1 (0.79) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL4629331 | 0.87 | L3MBTL1 (0.79) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL22111187 | 0.87 | L3MBTL1 (0.79) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL25512944 | 0.86 | L3MBTL1 (0.58) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL28388580 | 0.85 | KMT2A (0.62) | L3MBTL1KMT2APOLBNOD1FOLH1 | |
| SCHEMBL27761354 | 0.83 | CAD (0.58) | L3MBTL1KMT2APOLBNOD1FOLH1 | |
| SCHEMBL4628713 | 0.83 | L3MBTL1 (0.46) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL4628705 | 0.83 | L3MBTL1 (0.46) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL11124586 | 0.81 | L3MBTL1 (0.56) | L3MBTL1KMT2APOLBNOD1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1618117-B1 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | TRUSTEES EWHA WOMANS UNIVERSIT (KR) | 2008-04-23 | — | — | EP | disclosed |
| EP-1618117-A4 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | TRUSTEES EWHA WOMANS UNIVERSIT (KR) | 2007-04-11 | — | — | EP | disclosed |
| EP-1618117-A1 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | Board of Trustees, Ewha Womans University (KR) | 2006-01-25 | — | — | EP | disclosed |
| US-6951953-B2 | Tumor selective and biodegradable polyphosphazene-platinum(II) conjugate antitumor agent, and preparation method thereof | EWHA WOMANS UNIVERSITY (KR) | 2005-10-04 | — | — | US | disclosed |
| WO-2004096820-A1 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | BOARD OF TRUSTEES, EWHA WOMANS UNIVERSITY (KR) | 2004-11-11 | — | — | WO | disclosed |
| US-20040219127-A1 | Tumor selective and biodegradable polyphosphazene-platinum(II) conjugate antitumor agent, and preparation method thereof | EWHA WOMANS UNIVERSITY (KR) | 2004-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040219127-A1 | Tumor selective and biodegradable polyphosphazene-platinum(II) conjugate antitumor agent, and preparation method thereof | PHOSPHO1, FOLR1, PCNA | L3MBTL1 1674/4885KMT2A 1444/4885POLB 404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.